Beam Therapeutics Inc
NASDAQ:BEAM
Beam Therapeutics Inc
NASDAQ:BEAM
Price:
25.51
USD
-4.92%
Market Cap:
$2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
General Dynamics Corp
NYSE:GD
|
US |
|
Pan Pacific International Holdings Corp
TSE:7532
|
JP |
|
Klepierre SA
PAR:LI
|
FR |
|
New York Community Bancorp Inc
NYSE:NYCB
|
US |
|
W
|
Williams Companies Inc
F:WMB
|
US |
|
C
|
Cognizant Technology Solutions Corp
XHAM:COZ
|
US |
|
NRJ Group SA
F:NR8
|
FR |
|
Phunware Inc
F:2RJA
|
US |
|
C
|
Compagnie Financiere Richemont SA
F:RITN
|
CH |
|
V
|
Ventas Inc
F:VEN
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
E
|
Entra ASA
OSE:ENTRA
|
NO |
|
N
|
Nikkon Holdings Co Ltd
OTC:NIPKF
|
JP |
|
C
|
Copart Inc
SWB:CO6
|
US |
|
Chimera Investment Corp
LSE:0A7B
|
US |
|
TopBuild Corp
NYSE:BLD
|
US |
|
Merdeka Copper Gold Tbk PT
OTC:PMCGF
|
ID |
|
T
|
TAL Education Group
SWB:IZZ
|
CN |
|
M
|
Mitsubishi Estate Co Ltd
F:MES
|
JP |
Multiples-Based Value
The Multiples-Based Value for Beam Therapeutics Inc (BEAM) under the Base Case is hidden
USD.
Compared with the current market price of 25.51 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BEAM Multiples-Based Value
LOCKED
